IP Library Granted Patent US 11,759,116
Granted Patent B2
US 11,759,116 · App. 17/091,803 · Granted Sep 19, 2023

Determining blood flow using laser speckle imaging

Inventors: Sean Michael White (Santa Ana, CA); Bruce Yee Yang (Irvine, CA); Tyler Bywaters Rice (Santa Ana, CA)
Assignee: Covidien AG
A61B5/0261A61B5/0295A61B5/02241A61B5/7235A61B5/743
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,759,116
App. No.
17/091,803
Granted
Sep 19, 2023
Kind
B2
Abstract

In some examples, a system includes processing circuitry configured to generate a laser speckle contrast signal based on a received signal indicative of detected light, wherein the detected light is scatted by tissue from a coherent light source. The processing circuitry may also determine, from the laser speckle contrast signal, a flow value and determine, from the laser speckle contrast signal, a waveform metric. Based on the flow value and the waveform metric, the processing circuitry may determine a blood flow metric for the tissue and output a representation of the blood flow metric.

Claims (58)

1. A system comprising:

light drive circuitry configured to cause a coherent light source to emit light of a single wavelength;

light detection circuitry configured to generate a signal indicative of detected light;

processing circuitry configured to:

control the light drive circuitry to cause the coherent light source to emit the light of the single wavelength;

receive, from the light detection circuitry, the signal indicative of the detected light scattered from the light of the single wavelength;

generate a laser speckle contrast signal based on the signal indicative of the detected light, the detected light scattered by tissue of a subject and from the coherent light source that emitted the light of the single wavelength;

determine, from the laser speckle contrast signal, a flow value;

determine, from the laser speckle contrast signal, a waveform metric;

determine, based on both the flow value and the waveform metric, a blood flow metric for the tissue; and

output, for display at a display device, a representation of the blood flow metric.

2. The system of claim 1 , wherein the processing circuitry is configured to determine the waveform metric by at least determining the waveform metric based on the laser speckle contrast signal comprising at least one of a triphasic waveform, a biphasic waveform, or a monophasic waveform representative of a single cardiac cycle.

3. The system of claim 1 , wherein the processing circuitry is configured to determine the waveform metric by at least:

comparing a waveform shape of the laser speckle contrast signal to a plurality of different waveform templates; and

selecting the waveform metric corresponding to one waveform template of the plurality of different waveform templates that best fits the waveform shape.

4. The system of claim 1 , wherein the processing circuitry is configured to determine the blood flow metric based on a total score of the flow value and the waveform metric.

5. The system of claim 1 , wherein the processing circuitry is configured to determine the blood flow metric from a lookup table defining a relationship between the flow value and the waveform metric.

6. The system of claim 1 , wherein the processing circuitry is configured to:

determine the flow value by at least determining an average flow of a plurality of waveforms of the laser speckle contrast signal; and

determine the waveform metric by at least determining an average slope of the plurality of waveforms of the laser speckle contrast signal.

7. The system of claim 1 , wherein the processing circuitry is configured to determine a peripheral vascular disease metric based on the blood flow metric for the tissue.

8. The system of claim 1 , wherein the tissue comprises a digit of the subject.

9. The system of claim 1 , further comprising the display device configured to present the representation of the blood flow metric.

10. The system of claim 1 , further comprising:

the coherent light source; and

a light detector configured to detect light scattered by the tissue from the coherent light source and generate the signal indicative of the detected light.

11. A method comprising:

controlling, by processing circuitry, light drive circuitry configured to cause a coherent light source to emit light of a single wavelength;

generating, by light detection circuitry, a signal indicative of detected light scattered from the light of the single wavelength;

receiving, by the processing circuitry and from the light detection circuitry, the signal indicative of detected light;

generating, by the processing circuitry, a laser speckle contrast signal based on a the signal indicative of the detected light, the detected light scattered by tissue of a subject and from the coherent light source that emitted the light of the single wavelength;

determining, by the processing circuitry and from the laser speckle contrast signal, a flow value;

determining, by the processing circuitry and from the laser speckle contrast signal, a waveform metric;

determining, by the processing circuitry and based on both the flow value and the waveform metric, a blood flow metric for the tissue; and

outputting, by the processing circuitry and for display at a display device, a representation of the blood flow metric.

12. The method of claim 11 , wherein determining the waveform metric comprises determining the waveform metric based on the laser speckle contrast signal comprising one of a triphasic waveform, a biphasic waveform, or a monophasic waveform representative of a single cardiac cycle.

13. The method of claim 11 , wherein determining the waveform metric comprises:

comparing a waveform shape of the laser speckle contrast signal to a plurality of different waveform templates; and

selecting the waveform metric corresponding to one waveform template of the plurality of different waveform templates that best fits the waveform shape.

14. The method of claim 11 , wherein determining the blood flow metric comprises determining the blood flow metric based on a total score of the flow value and the waveform metric.

15. The method of claim 11 , wherein determining the blood flow metric comprises determining the blood flow metric from a lookup table defining a relationship between the flow value and the waveform metric.

16. The method of claim 11 , wherein:

determining the flow value comprises calculating an average flow of a plurality of waveforms of the laser speckle contrast signal; and

determining the waveform metric comprises calculating an average slope of the plurality of waveforms of the laser speckle contrast signal.

17. The method of claim 11 , further comprising determining a peripheral vascular disease metric based on the blood flow metric for the tissue.

18. The method of claim 11 , wherein the tissue comprises a digit of a subject, and wherein the method further comprises:

delivering, via the coherent light source, the coherent light to the tissue of the digit;

detecting, via a light detector, the light scattered by the tissue of the digit from the coherent light source; and

generating, via the light detector and by the light detection circuitry, the signal indicative of the detected light.

19. The method of claim 11 , further comprising presenting, via the display device, the representation of the blood flow metric.

20. A non-transitory computer-readable medium comprising instructions that, when executed, causes processing circuitry to:

control light drive circuitry to cause a coherent light source to emit light of a single wavelength;

receive, from light detection circuitry, a signal indicative of detected light, wherein the light detection circuitry is configured to generate the signal indicative of the detected light;

generate a laser speckle contrast signal based on the signal indicative of the detected light, the detected light scattered by tissue of a subject and from the coherent light source that emitted the light of the single wavelength;

determine, from the laser speckle contrast signal, a flow value;

determine, from the laser speckle contrast signal, a waveform metric;

determine, based on both the flow value and the waveform metric, a blood flow metric for the tissue; and

output, for display at a display device, a representation of the blood flow metric.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2021
From: RICE, TYLER BYWATERS
To: COVIDIEN LP
Reel/Frame 056780/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2021
From: COVIDIEN LP
To: COVIDIEN AG
Reel/Frame 056780/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: WHITE, SEAN MICHAEL; YANG, BRUCE YEE
To: COVIDIEN LP
Reel/Frame 055416/0596 →
Continuity (2)
Provisional Application 62948506 · Dec 16, 2019
Related Publication 20210177283A1 · Jun 17, 2021
Cited By (5)
US 12,201,396 US 12,390,117 US 12,396,648 US 12,484,796 US 12,685,449